Lungpacer Medical announced that it received FDA investigational device exemption (IDE) approval to begin a trial for its AeroNova system.

Lungpacer Medical has announced that the U.S. Food and Drug Administration (FDA) has approved an Investigational Device ...

Lungpacer Medical, a leading neurostimulation company committed to advancing therapies that assist patients in overcoming the negative effects of mechanical ventilation (MV), is excited to announce ...